Activation and signaling of the p38 MAP kinase pathway
Tóm tắt
Từ khóa
Tài liệu tham khảo
Rouse J, Cohen P, Trigon S, et al. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 1994; 78:1027–37.
Han J, Lee JD, Tobias PS, Ulevitch RJ . Endotoxin induces rapid protein tyrosine phosphorylation in 70Z/3 cells expressing CD14. J Biol Chem 1993; 268:25009–14.
Han J, Lee JD, Bibbs L, Ulevitch RJ . A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 1994; 265:808–11.
Lee JC, Laydon JT, McDonnell PC, et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994; 372:739–46.
Jiang Y, Chen C, Li Z, et al. Characterization of the structure and function of a new mitogen-activated protein kinase (p38β). J Biol Chem 1996; 271:17920–6.
Lechner C, Zahalka MA, Giot JF, Moler NPH, Ullrich A . ERK6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation. Proc Natl Acad Sci USA 1996; 93:4355–9.
Li Z, Jiang Y, Ulevitch RJ, Han J . The primary structure of p38gamma: A new member of p38 group of MAP kinase. Biochem Biophys Res Comm 1996; 228:334–40.
Jiang Y, Gram H, Zhao M, et al. Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38delta. J Biol Chem 1997; 272:30122–8.
Kumar S, McDonnell PC, Gum RJ, et al. Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem Biophys Res Commun 1997; 235:533–8.
Hanks SK, Hunter T . The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J 1999; 9:576–96.
Han SJ, Choi KY, Brey PT, Lee WJ . Molecular cloning and characterization of a Drosophila p38 mitogen-activated protein kinase. J Biol Chem 1998; 273:369–74.
Brewster JL, de Valoir T, Dyer ND, Winter E, Gustin MC . An osmosensing signal transduction pathway in yeast. Science 1993; 259:1760–3.
Shiozaki K, Russell P . Cell-cycle control linked to extracellular environment by MAP kinase pathway in fission yeast. Nature 1995; 378:739–43.
Shiozaki K, Russell P . Conjugation, meiosis, and the osmotic stress response are regulated by Spc1 kinase through Atf1 transcription factor in fission yeast. Genes Dev 1996; 10:2276–88.
Freshney NW, Rawlinson L, Guesdon F, et al. Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell 1994; 78:1039–49.
Lee JC, Laydon JT, McDonnell PC, et al. Identification and characterization of a novel protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994; 372:739–46.
Raingeaud J, Gupta S, Rogers JS, et al. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 1995; 270:7420–6.
Pietersma A, Tilly BC, Gaestel M, et al. p38 mitogen activated protein kinase regulates endothelial VCAM-1 expression at the post-transcriptional level. Biochem Biophys Res Comm 1997; 230:44–8.
Shalom-Barak T, Quach J, Lotz M . Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB. J Biol Chem 1998; 273:27467–73.
Shapiro L, Puren AJ, Barton HA, et al. Interleukin 18 stimulates HIV type 1 in monocytic cells. Proc Natl Acad Sci U S A 1998; 95:12550–5.
Foltz IN, Lee JC, Young PR, Schrader JW . Hemopoietic growth factors with the exception of interleukin-4 activate the p38 mitogen-activated protein kinase pathway. J Biol Chem 1997; 272:3296–3301.
Sweeney G, Somwar R, Ramlal T, et al. An inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes. J Biol Chem 1999; 274:10071–8.
Heidenreich KA, Kummer JL . Inhibition of p38 mitogen-activated protein kinase by insulin in cultured fetal neurons. J Biol Chem 1996; 271:9891–4.
Hu MC, Wang YP, Mikhail A, Qiu WR, Tan TH . Murine p38-delta mitogen-activated protein kinase, a developmentally regulated protein kinase that is activated by stress and proinflammatory cytokines. J Biol Chem 1999; 274:7095–102.
Cuenda A, Cohen P, Buee-Scherrer V, Goedert M . Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK/p38). EMBO J 1997; 16:295–305.
Enslen H, Raingeaud J, Davis RJ . Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J Biol Chem 1998; 273:1741–8.
Parker CG, Hunt J, Diener K, et al. Identification of stathmin as a novel substrate for p38 delta. Biochem Biophys Res Commun 1998; 249:791–6.
Ge B, Gram H, Di Padova F, et al. MAPKK-independent activation of p38alpha mediated by TAB1-dependent autophosphorylation of p38alpha. Science 2002; 295:1291–4.
Brancho D, Tanaka N, Jaeschke A, et al. Mechanism of p38 MAP kinase activation in vivo. Genes Dev 2003; 17:1969–78.
Ohkusu-Tsukada K, Tominaga N, Udono H, Yui K . Regulation of the maintenance of peripheral T-cell anergy by TAB1-mediated p38 alpha activation. Mol Cell Biol 2004; 24:6957–66.
Matsuyama W, Faure M, Yoshimura T . Activation of discoidin domain receptor 1 facilitates the maturation of human monocyte-derived dendritic cells through the TNF receptor associated factor 6/TGF-beta-activated protein kinase 1 binding protein 1 beta/p38 alpha mitogen-activated protein kinase signaling cascade. J Immunol 2003; 171:3520–32.
Tanno M, Bassi R, Gorog DA, et al. Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia. Circ Res 2003; 93:254–61.
Moriguchi T, Kuroyanagi N, Yamaguchi K, et al. A novel kinase cascade mediated by mitogen-activated protein kinase kinase 6 and MKK3. J Biol Chem 1996; 271:13675–9.
Ichijo H, Nishida E, Irie K, et al. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 1997; 275:90–4.
Hirai S, Katoh M, Terada M, et al. MST/MLK2, a member of the mixed lineage kinase family, directly phosphorylates and activates SEK1, an activator of c-Jun N- terminal kinase/stress-activated protein kinase. J Biol Chem 1997; 272:15167–73.
Ubeda M, Wang XZ, Zinszner H, et al. Stress-induced binding of the transcriptional factor CHOP to a novel DNA control element. Mol Cell Biol 1996; 16:1479–89.
Cuenda A, Dorow DS . Differential activation of stress-activated protein kinase kinases SKK4/MKK7 and SKK1/MKK4 by the mixed-lineage kinase-2 and mitogen-activated protein kinase kinase (MKK) kinase-1. Biochem J 1998; 333:11–5.
Takekawa M, Posas, F, Saito H . A human homolog of the yeast Ssk2/Ssk22 MAP kinase kinase kinases, MTK1, mediates stress-induced activation of the p38 and JNK pathways. EMBO J 1997; 16:4973–82.
Ogura M, Kitamura M . Oxidant stress incites spreading of macrophages via extracellular signal-regulated kinases and p38 mitogen-activated protein kinase. J Immunol 1998; 161:3569–74.
Zhang S, Han J, Sells MA, et al. Rho family GTPases regulate p38 MAP kinase through the downstream mediator Pak1. J Biol Chem 1995; 270:23934–6.
Bagrodia S, Derijard B, Davis RJ, Cerione RA . Cdc42 and PAK-mediated signaling leads to Jun kinase and p38 mitogen-activated protein kinase activation. J. Biol. Chem 1995; 270:27995–8.
Tibbles LA, Ing YL, Kiefer F, et al. MLK-3 activates the SAPK/JNK and p38/RK pathways via SEK1 and MKK3/6. EMBO J 1996; 15:7026–35.
Martin GA, Bollag G, McCormick, F, Abo A . A novel serine kinase activated by rac1/CDC42Hs-dependent autophosphorylation is related to PAK65 and STE20. EMBO J 1995; 14:1970–8.
Manser E, Leung T, Salihuddin H ., Zhao Z, Lim L . A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature 1994; 367:40–6.
Sun H, Charles CH, Lau LF, Tonks NK . MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 1993; 75:487–93.
Camps M, Nichols A, Gillieron C, et al. Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase. Science 1998; 280:1262–5.
Muda M, Theodosiou A, Rodrigues N, et al. The dual specificity phosphatases M3/6 and MKP-3 are highly selective for inactivation of distinct mitogen-activated protein kinases. J Biol Chem 1996; 271:27205–8.
Maeda T, Wurgler-Murphy SM, Saito H . A two-component system that regulates an osmosensing MAP kinase cascade in yeast. Nature 1994; 369:242–5.
Posas F, Wurgler-Murphy SM, Maeda T, et al. Yeast HOG1 MAP kinase cascade is regulated by a multistep phosphorelay mechanism in the SLN1-YPD1-SSK1 “two-component” osmosensor. Cell 1996; 86:865–75.
Wurgler-Murphy SM, Maeda T, Witten EA, Saito H . Regulation of the Saccharomyces cerevisiae HOG1 mitogen- activated protein kinase by the PTP2 and PTP3 protein tyrosine phosphatases. Mol Cell Biol 1997; 17:1289–97.
Takekawa M, Maeda T, Saito H . Protein phosphatase 2Calpha inhibits the human stress-responsive p38 and JNK MAPK pathways. EMBO J 1998; 17:4744–52.
McLaughlin MM, Kumar S, McDonnell PC, et al. Identification of mitogen-activated protein (MAP) kinase-activated protein kinase-3, a novel substrate of CSBP p38 MAP kinase. J Biol Chem 1996; 271:8488–92.
Stokoe D, Engel K, Campbell DG, Cohen P, Gaestel M . Identification of MAPKAP kinase 2 as a major enzyme responsible for the phosphorylation of the small mammalian heat shock proteins. FEBS 1992; 313:307–13.
Huang CK, Zhan L, Ai Y, Jongstra J . LSP1 is the major substrate for mitogen-activated protein kinase- activated protein kinase 2 in human neutrophils. J Biol Chem 1997; 272:17–9.
Tan Y, Rouse J, Zhang A, et al. FGF and stress regulate CREB, ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2. EMBO J 1996; 15:4629–42.
Heidenreich O, Neininger A, Schratt G, et al. MAPKAP kinase 2 phosphorylates serum response factor in vitro and in vivo. J Biol Chem 1999; 274:14434–43.
Thomas G, Haavik J, Cohen P . Participation of a stress-activated protein kinase cascade in the activation of tyrosine hydroxylase in chromaffin cells. Eur J Biochem 1997; 247:1180–9.
Mahtani KR, Brook M, Dean JL, et al. Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mol Cell Biol 2001; 21:6461–9.
Waskiewicz AJ, Flynn A, Proud CG, Cooper JA . Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J 1997; 16:1909–20.
Fukunaga R, Hunter T . MNK1, a new MAP kinase-activated protein kinase, solated by a novel expression screening method for identifying protein kinase substrates. EMBO J 1997; 16:1921–33.
New L, Jiang Y, Zhao M, et al. PRAK, a novel protein kinase regulated by the p38 MAP kinase. EMBO J 1998; 17:3372–84.
Deak M, Clifton AD, Lucocq LM, Alessi DR . Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J 1998; 17:4426–41.
Pierrat B, Correia JS, Mary JL, Tomas-Zuber M, Lesslauer W . RSK-B, a novel ribosomal S6 kinase family member, is a CREB kinase under dominant control of p38alpha mitogen-activated protein kinase (p38alphaMAPK). J Biol Chem 1998; 273:29661–71.
New L, Zhao M, Li Y, et al. Cloning and characterization of RLPK, a novel RSK-related protein kinase. J Biol Chem 1999; 274:1026–32.
Zheng L, Roeder RG, Luo Y . S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component. Cell 2003; 114:255–66.
Hazzalin CA, Cano E, Cuenda A, et al. p38/RK is essential for stress-induced nuclear responses: JNK/SAPKs and c-Jun/ATF-2 phosphorylation are insufficient. Curr Biol 1996; 6:1028–31.
Whitmarsh AJ, Yang SH, Su MS, Sharrocks AD, Davis RJ . Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors. Mol Cell Biol 1997; 17:2360–71.
Janknecht R, Hunter T . Convergence of MAP kinase pathways on the ternary complex factor Sap-1a. EMBO J 1997; 16:1620–7.
Wang XZ, Ron D . Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP Kinase. Science 1996; 272:1347–9.
Han J, Jiang Y, Li Z, Kravchenko VV, Ulevitch RT . Activation of the t transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature 1997; 386:296–9.
Zhao M, New L, Kravchenko VV, et al. Regulation of the MEF2 family of transcription factors by p38. Mol Cell Biol 1999; 19:21–30.
Huang C, Ma WY, Maxiner A, Sun Y, Dong Z . p38 kinase mediates UV-induced phosphorylation of p53 protein at serine 389. J Biol Chem 1999; 274:12229–35.
Yee AS, Paulson EK, McDevitt MA, et al. The HBP1 transcriptional repressor and the p38 MAP kinase: unlikely partners in G1 regulation and tumor suppression. Gene 2004; 336:1–13.
Galibert MD, Carreira S, Goding CR . The Usf-1 transcription factor is a novel target for the stress- responsive p38 kinase and mediates UV-induced Tyrosinase expression. EMBO J 2001; 20:5022–31.
Pereira RC, Delany AM, Canalis E . CCAAT/enhancer binding protein homologous protein (DDIT3) induces osteoblastic cell differentiation. Endocrinology 2004; 145:1952–60.
Gomez del Arco P, Martinez-Martinez S, Maldonado JL, Ortega-Perez I, Redondo JM . A role for the p38 MAP kinase pathway in the nuclear shuttling of NFATp. J Biol Chem 2000; 275:13872–8.
Kramer RM, Roberts EF, Um SL, et al. p38 mitogen-activated protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2) in thrombin-stimulated platelets. Evidence that proline-directed phosphorylation is not required for mobilization of arachidonic acid by cPLA2. J Biol Chem 1996; 271:27723–9.
Kusuhara M, Takahashi E, Peterson TE, et al. p38 Kinase is a negative regulator of angiotensin II signal t transduction in vascular smooth muscle cells: effects on Na+/H+ exchange and ERK1/2. Circ Res 1998; 83:824–31.
Reynolds CH ., Nebreda AR, Gibb GM ., Utton MA, Anderton BH . Reactivating kinase/p38 phosphorylates tau protein in vitro. J Neurochem 1997; 69:191–8.
Feng L, Zhou X, Liao J, Omary MB . Pervanadate-mediated tyrosine phosphorylation of keratins 8 and 19 via a p38 mitogen-activated protein kinase-dependent pathway. J Cell Sci 1999; 112:2081–90.
Young P, McDonnell P, Dunnington D, et al. Pyridinyl imidazoles inhibit IL-1 and TNF production at the protein level. Agents Actions 1993; 39:C67–9.
Prichett W, Hand A, Sheilds J, Dunnington D . Mechanism of action of bicyclic imidazoles defines a translational regulatory pathway for tumor necrosis factor alpha. J Inflamm 1995; 45:97–105.
Kotlyarov A, Neininger A, Schubert C, et al. MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat Cell Biol 1999; 1:94–7.
Kontoyiannis D, Kotlyarov A, Carballo E, et al. Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology. EMBO J 2001; 20:3760–70.
Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G . Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 1999; 10:387–98.
Sweeney SE, Firestein GS . Signal transduction in rheumatoid arthritis. Curr Opin Rheumatol 2004; 16:231–7.
Johnson GV, Bailey CD . The p38 MAP kinase signaling pathway in Alzheimer's disease. Exp Neurol 2003; 183:263–8.
Hollenbach E, Neumann M, Vieth M, et al. Inhibition of p38 MAP kinase- and RICK/NF-kappaB-signaling suppresses inflammatory bowel disease. FASEB J 2004; 13:1550–2.
Perregaux DG, Dean D, Cronan M, Connelly P, Gabel C. A . Inhibition of interleukin-1 beta production by SKF86002: evidence of two sites of in vitro activity and of a time and system dependence. Mol Pharmacol 1995; 48:433–42.
Guan Z, Buckman SY, Pentland AP, Templeton DJ, Morrison AR . Induction of cyclooxygenase-2 by the activated MEKK1 —> SEK1/MKK4 —> p38 mitogen-activated protein kinase pathway. J Biol Chem 1998; 273:12901–8.
Badger AM, Cook MN, Lark MW, et al. SB 203580 inhibits p38 mitogen-activated protein kinase, nitric oxide production, and inducible nitric oxide synthase in bovine cartilage-derived chondrocytes. J Immunol 1998; 161:467–73.
Da Silva J, Pierrat B, Mary JL, Lesslauer W . Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitric-oxide synthase expression in mouse astrocytes. J Biol Chem 1997; 272:28373–80.
Craxton A, Shu G, Graves JD, et al. p38 MAPK is required for CD40-induced gene expression and proliferation in B lymphocytes. J Immunol 1998; 161:3225–36.
Kummer JL, Rao PK, Heidenreich KA . Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase. J Biol Chem 1997; 272:20490–4.
Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME . Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995; 270:1326–31.
Juo P, Kuo CJ, Reynolds SE, et al. Fas activation of the p38 mitogen-activated protein kinase signalling pathway requires ICE/CED-3 family proteases. Mol Cell Biol 1997; 17:24–35.
Fernandes-Alnemri T, Armstrong RC, Krebs J, et al. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc Natl Acad Sci U S A 1996; 93:7464–9.
Cahill MA, Peter ME, Kischkel FC, et al. CD95 (APO-1/Fas) induces activation of SAP kinases downstream of ICE-like proteases. Oncogene 1996; 13:2087–96.
Huang S, Jiang Y, Li Z, et al. Apoptosis signaling pathway in T cells is composed of ICE/Ced-3 family proteases and MAP kinase kinase 6β. Immunity 1997; 6:739–49.
Cardone MH, Salvesen GS, Widmann C, Johnson G, Frisch SM . The regulation of anoikis: MEKK-1 activation requires cleavage by caspases. Cell 1997; 90:315–23.
Ziegler-Heitbrock HW, Blumenstein M, Kafferlein E, et al. In vitro desensitization to lipopolysaccharide suppresses tumour necrosis factor, interleukin-1 and interleukin-6 gene expression in a similar fashion. Immunology 1992; 75:264–8.
Takenaka K, Moriguchi T, Nishida E . Activation of the protein kinase p38 in the spindle assembly checkpoint and mitotic arrest. Science 1998; 280:599–602.
Molnar A, Theodoras AM, Zon LI, Kyriakis JM . Cdc42Hs, but not Rac1, inhibits serum-stimulated cell cycle progression at G1/S through a mechanism requiring p38/RK. J Biol Chem 1997; 272:13229–35.
Wang X, McGowan CH, Zhao M, et al. Involvement of the MKK6-p38gamma cascade in gamma-radiation- induced cell cycle arrest. Mol Cell Biol 2000; 20:4543–52.
Wang Y, Huang S, Sah VP, et al. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem 1998; 273:2161–8.
Tamura K, Sudo T, Senftleben U, et al. Requirement for p38alpha in erythropoietin expression: a role for stress kinases in erythropoiesis. Cell 2000; 102:221–31.
Mudgett JS, Ding J, Guh-Siesel L, et al. Essential role for p38alpha mitogen-activated protein kinase in placental angiogenesis. Proc Natl Acad Sci U S A 2000; 97:10454–9.
Adams RH, Porras A, Alonso G, et al. Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development. Mol. Cell 2000; 6:109–16.
Nagata Y, Todokoro K . Requirement of activation of JNK and p38 for environmental stress-induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis. Blood 1999; 94:853–63.
Natale DR, Paliga AJ, Beier F, D'Souza SJ, Watson AJ . p38 MAPK signaling during murine preimplantation development. Dev Biol 2004; 268:76–88.
Morooka T, Nishida E . Requirement of p38 mitogen-activated protein kinase for neuronal differentiation in PC12 cells. J Biol Chem 1998; 273:24285–8.
Engelman JA, Lisanti MP, Scherer PE . Specific inhibitors of p38 mitogen-activated protein kinase block 3T3- L1 adipogenesis. J Biol Chem 1998; 273:32111–20.
Nagata Y, Takahashi N, Davis RJ, Todokoro K . Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation. Blood 1998; 92:1859–69.
Li Y, Jiang B, Ensign WY, Vogt PK, Han J . Myogenic differentiation requires signalling through both phosphatidylinositol 3-kinase and p38 MAP kinase. Cell Signal 2000; 12:751–7.
Iwasa H ., Han J, Ishikawa F . Mitogen-activated protein kinase p38 defines the common senescence-signalling pathway. Genes Cells 2003; 8:131–44.
Wang W, Chen JX, Liao R, et al. Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence. Mol Cell Biol 2002; 22:3389–403.
Haq R, Brenton JD, Takahashi M, et al. Constitutive p38HOG mitogen-activated protein kinase activation induces permanent cell cycle arrest and senescence. Cancer Res 2002; 62:5076–82.